Trends in the Cost and Utilization of Omalizumab in the Medicare Population: 2013-2017.
Cheraghlou S, Ugwu N, Yu B, Cohen JM. Trends in the Cost and Utilization of Omalizumab in the Medicare Population: 2013-2017. The Yale Journal Of Biology And Medicine 2022, 95: 207-212. PMID: 35782473, PMCID: PMC9235260.Peer-Reviewed Original Research